UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$438M |
| 2 |
Lockheed Martin
LMT
|
+$402M |
| 3 |
TAL Education Group
TAL
|
+$294M |
| 4 |
Microsoft
MSFT
|
+$269M |
| 5 |
Wells Fargo
WFC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$384M |
| 2 |
Adobe
ADBE
|
+$372M |
| 3 |
Veeva Systems
VEEV
|
+$342M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$289M |
| 5 |
Global Payments
GPN
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.1% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Cato Corp
CATO
$66.1M
| – | – |
-30,878
| Closed | -$241K |
|
2502
Chord Energy
CHRD
$7.39B
| – | – |
-1,060,309
| Closed | -$297K |
|
2503
Corbus Pharmaceuticals
CRBP
$190M
| – | – |
-1,707
| Closed | -$92.2K |
|
|
CRON
2504
Cronos Group
CRON
$1.14B
| – | – |
-551,497
| Closed | -$2.76M |
|
2505
Canadian Solar
CSIQ
$1.08B
| – | – |
-8,000
| Closed | -$281K |
|
2506
Ezcorp Inc
EZPW
$1.71B
| – | – |
-71,728
| Closed | -$361K |
|
2507
JFrog
FROG
$10.8B
| – | – |
-20,096
| Closed | -$1.7M |
|
2508
SPDR Gold Trust
GLD
$142B
| – | – |
-332
| Closed | -$58.8K |
|
2509
Greenlight Captial
GLRE
$506M
| – | – |
-15,510
| Closed | -$104K |
|
2510
GSK
GSK
$106B
| – | – |
-66,640
| Closed | -$3.14M |
|
2511
Hanmi Financial
HAFC
$946M
| – | – |
-21,209
| Closed | -$174K |
|
2512
ORIX
IX
$43.5B
| – | – |
-1,648,805
| Closed | -$20.6M |
|
|
JKS
2513
JinkoSolar
JKS
$891M
| – | – |
-7,800
| Closed | -$310K |
|
2514
Marcus Corp
MCS
$945M
| – | – |
-14,845
| Closed | -$115K |
|
2515
Matrix Service
MTRX
$335M
| – | – |
-20,794
| Closed | -$174K |
|
2516
National CineMedia
NCMI
$378M
| – | – |
-9,193
| Closed | -$250K |
|
2517
Northern Oil and Gas
NOG
$2.35B
| – | – |
-10,620
| Closed | -$61K |
|
2518
Nomad Foods
NOMD
$1.68B
| – | – |
-8,737
| Closed | -$223K |
|
2519
Outset Medical
OM
$90.8M
| – | – |
-1,474
| Closed | -$1.11M |
|
2520
Paysign
PAYS
$705M
| – | – |
-30,400
| Closed | -$173K |
|
|
PDS
2521
Precision Drilling
PDS
$974M
| – | – |
-1,878
| Closed | -$23.3K |
|
2522
Park Aerospace
PKE
$819M
| – | – |
-15,062
| Closed | -$164K |
|
|
PR
2523
Permian Resources
PR
$16.9B
| – | – |
-149,800
| Closed | -$90.2K |
|
2524
Quince Therapeutics
QNCX
$29.5M
| – | – |
-71
| Closed | -$707K |
|
2525
Regis Corp
RGS
$70.2M
| – | – |
-949
| Closed | -$116K |
|
Similar funds
UBS AM's Q4 2020 Portfolio in Review
As of Q4 2020, UBS AM held 2,632 positions worth $213B, up 15% from $186B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM's Q4 2020 filing shows 139 new, 1,393 increased, 625 reduced and 83 closed positions. Its largest new stake was Maravai LifeSciences: 3,763,012 shares worth $106M. The largest sale was Mastercard, an estimated $384M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q4 2020 buy was Maravai LifeSciences: 3,763,012 shares worth $106M.
- UBS AM added most to Apple in Q4 2020, an estimated $438M increase.
- UBS AM's biggest Q4 2020 reduction was Mastercard, cutting an estimated $384M.
- UBS AM fully exited State Street Technology Select Sector SPDR ETF in Q4 2020, selling an estimated $115M.
- UBS AM's ten largest holdings make up 23% of its $213B portfolio in Q4 2020.
- UBS AM opened 139 new positions and closed 83 in Q4 2020.
- UBS AM's portfolio value rose 15% quarter-over-quarter to $213B.
Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.